To investigate whether this synergistic effect applied in the setting of CRC, CRC was induced in WT mice using AOM/DSS and mice were treated with either control, RIPK2 inhibitor, or TRAF6 inhibitor, alone or in combination, twice a week for the entire duration of CRC induction (Fig. 6o). This evidence concerns the gene RIPK2 and colorectal carcinoma.